These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 23818033

  • 1. Systemic treatment with the sphingosine-1-phosphate analog FTY720 does not improve fracture healing in mice.
    Heilmann A, Schinke T, Bindl R, Wehner T, Rapp A, Haffner-Luntzer M, Liedert A, Amling M, Ignatius A.
    J Orthop Res; 2013 Nov; 31(11):1845-50. PubMed ID: 23818033
    [Abstract] [Full Text] [Related]

  • 2. Sphingosine 1-phosphate receptor modulator fingolimod (FTY720) does not promote remyelination in vivo.
    Hu Y, Lee X, Ji B, Guckian K, Apicco D, Pepinsky RB, Miller RH, Mi S.
    Mol Cell Neurosci; 2011 Sep; 48(1):72-81. PubMed ID: 21740973
    [Abstract] [Full Text] [Related]

  • 3. Topical treatment targeting sphingosine-1-phosphate and sphingosine lyase abrogates experimental allergic rhinitis in a murine model.
    Kleinjan A, van Nimwegen M, Leman K, Hoogsteden HC, Lambrecht BN.
    Allergy; 2013 Feb; 68(2):204-12. PubMed ID: 23253209
    [Abstract] [Full Text] [Related]

  • 4. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
    Lan YY, Tokita D, Wang Z, Wang HC, Zhan J, Brinkmann V, Thomson AW.
    Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
    [Abstract] [Full Text] [Related]

  • 5. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Nofer JR, Bot M, Brodde M, Taylor PJ, Salm P, Brinkmann V, van Berkel T, Assmann G, Biessen EA.
    Circulation; 2007 Jan 30; 115(4):501-8. PubMed ID: 17242282
    [Abstract] [Full Text] [Related]

  • 6. Sphingosine 1-phosphate receptor type 1 regulates egress of mature T cells from mouse bone marrow.
    Maeda Y, Seki N, Sato N, Sugahara K, Chiba K.
    Int Immunol; 2010 Jun 30; 22(6):515-25. PubMed ID: 20497959
    [Abstract] [Full Text] [Related]

  • 7. The sphingosine-1-phosphate analogue FTY720 reduces atherosclerosis in apolipoprotein E-deficient mice.
    Keul P, Tölle M, Lucke S, von Wnuck Lipinski K, Heusch G, Schuchardt M, van der Giet M, Levkau B.
    Arterioscler Thromb Vasc Biol; 2007 Mar 30; 27(3):607-13. PubMed ID: 17158351
    [Abstract] [Full Text] [Related]

  • 8. The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1.
    Schmid G, Guba M, Ischenko I, Papyan A, Joka M, Schrepfer S, Bruns CJ, Jauch KW, Heeschen C, Graeb C.
    J Cell Biochem; 2007 May 01; 101(1):259-70. PubMed ID: 17203465
    [Abstract] [Full Text] [Related]

  • 9. Distinct frequency dependent effects of whole-body vibration on non-fractured bone and fracture healing in mice.
    Wehrle E, Wehner T, Heilmann A, Bindl R, Claes L, Jakob F, Amling M, Ignatius A.
    J Orthop Res; 2014 Aug 01; 32(8):1006-13. PubMed ID: 24729351
    [Abstract] [Full Text] [Related]

  • 10. Fingolimod (FTY720), sphingosine 1-phosphate receptor modulator, shows superior efficacy as compared with interferon-β in mouse experimental autoimmune encephalomyelitis.
    Chiba K, Kataoka H, Seki N, Shimano K, Koyama M, Fukunari A, Sugahara K, Sugita T.
    Int Immunopharmacol; 2011 Mar 01; 11(3):366-72. PubMed ID: 20955831
    [Abstract] [Full Text] [Related]

  • 11. FTY720 inhibits S1P-mediated endothelial healing: relationship to S1P1-receptor surface expression.
    Krump-Konvalinkova V, Chwalla I, Siess W.
    Biochem Biophys Res Commun; 2008 Jun 13; 370(4):603-8. PubMed ID: 18402775
    [Abstract] [Full Text] [Related]

  • 12. Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator.
    Ter Braak M, Claas RF, Hegen B, Labocha S, Ferreirós N, Pfeilschifter J, Huwiler A, van Echten-Deckert G, Meyer Zu Heringdorf D.
    Biochem Pharmacol; 2011 Mar 01; 81(5):617-25. PubMed ID: 21163254
    [Abstract] [Full Text] [Related]

  • 13. Osteoclast depletion with clodronate liposomes delays fracture healing in mice.
    Lin HN, O'Connor JP.
    J Orthop Res; 2017 Aug 01; 35(8):1699-1706. PubMed ID: 27653179
    [Abstract] [Full Text] [Related]

  • 14. Melatonin impairs fracture healing by suppressing RANKL-mediated bone remodeling.
    Histing T, Anton C, Scheuer C, Garcia P, Holstein JH, Klein M, Matthys R, Pohlemann T, Menger MD.
    J Surg Res; 2012 Mar 01; 173(1):83-90. PubMed ID: 20888595
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor.
    Trifilieff A, Fozard JR.
    J Pharmacol Exp Ther; 2012 Aug 01; 342(2):399-406. PubMed ID: 22570366
    [Abstract] [Full Text] [Related]

  • 18. FTY720 (fingolimod) sensitizes prostate cancer cells to radiotherapy by inhibition of sphingosine kinase-1.
    Pchejetski D, Bohler T, Brizuela L, Sauer L, Doumerc N, Golzio M, Salunkhe V, Teissié J, Malavaud B, Waxman J, Cuvillier O.
    Cancer Res; 2010 Nov 01; 70(21):8651-61. PubMed ID: 20959468
    [Abstract] [Full Text] [Related]

  • 19. The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
    Deguchi Y, Andoh A, Yagi Y, Bamba S, Inatomi O, Tsujikawa T, Fujiyama Y.
    Oncol Rep; 2006 Oct 01; 16(4):699-703. PubMed ID: 16969482
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.